NDC 68151-4295

RENAGEL

Renagel

RENAGEL is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Sevelamer Hydrochloride.

Product ID68151-4295_659e4de8-1232-4c9e-ab20-7e0d3af01700
NDC68151-4295
Product TypeHuman Prescription Drug
Proprietary NameRENAGEL
Generic NameRenagel
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2008-06-06
Marketing CategoryNDA / NDA
Application NumberNDA021179
Labeler NameCarilion Materials Management
Substance NameSEVELAMER HYDROCHLORIDE
Active Ingredient Strength400 mg/1
Pharm ClassesPhosphate Binder [EPC],Phosphate Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 68151-4295-1

1 TABLET in 1 BLISTER PACK (68151-4295-1)
Marketing Start Date2017-12-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68151-4295-1 [68151429501]

RENAGEL TABLET
Marketing CategoryNDA
Application NumberNDA021179
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-12-28
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
SEVELAMER HYDROCHLORIDE400 mg/1

OpenFDA Data

SPL SET ID:9281598e-60de-4f4f-8e01-0a7dfef92dd3
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 857218
  • 857216
  • Pharmacological Class

    • Phosphate Binder [EPC]
    • Phosphate Chelating Activity [MoA]

    NDC Crossover Matching brand name "RENAGEL" or generic name "Renagel"

    NDCBrand NameGeneric Name
    17856-0021RenagelRenagel
    53808-0777RenagelRenagel
    58468-0020RenagelRenagel
    58468-0021Renagelsevelamer hydrochloride
    67544-656RenagelRenagel
    68151-4295RENAGELRenagel

    Trademark Results [RENAGEL]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RENAGEL
    RENAGEL
    74590044 1978935 Live/Registered
    GENZYME CORPORATION
    1994-10-24

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.